Beyond Smoking: Understanding ALL Lung Cancer Risk Factors

4 New LCFA Board Members

LCFA in the News

Meet LCFA's Newest Board Members

LCFA adds four dynamic leaders to its board

Learn more

Meet the Researchers

View All
  • Julie Wu, MD

    Staff Physician, Medical Oncology

    Precision oncology integrating evidence-based models into clinical practice to personalize treatment approaches

  • Jonathan Villena-Vargas, MD

    Thoracic Surgeon

    Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients

  • Kellie Smith, PhD

    Leading an immunology lab in transformative cancer research

    Immunotherapy in Early Stage Lung Cancer

Recently diagnosed with lung cancer?

Learn more about your lung cancer diagnosis. What questions should you be asking? What are the most important next steps? Know that you have options and remember that knowledge is power.

Meet people living with lung cancer

More Stories
View all

Word of the Day

STK11

STK11 is a mutation in the STK11 protein and is one biomarker that physicians look for in non-small cell lung cancer. STK11 was first discovered in 1996. Everyone has two STK11 genes (one from their mother and one from their father). If one of the genes is not working, this is known as having a faulty STK11 gene or having an STK11 mutation.